MedPath

Short-term outcomes of intravesical heparin therapy for bladder pain syndrome; a single-blinded randomized controlled trial

Phase 2
Conditions
Bladder pain syndrome
Intravesical heparin instillation
Efficacy
Registration Number
TCTR20180912004
Lead Sponsor
Siriraj Institutional Review Board
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
Female
Target Recruitment
62
Inclusion Criteria

Bladder pain syndrome
VAS >/= 4

Exclusion Criteria

Allergy to heparin
History of gross hematuria
History of coagulopathy
Pregnancy and lactation
Patients who have received previous treatment for bladder pain syndrome

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath